Skip to main content
logo
Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
6.94
+0.33 (4.99%)
May 21, 2026, 3:00 PM CST

SHA:605199 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,7773,0496,3746,0666,4109,971
Market Cap Growth
-54.61%-52.17%5.08%-5.37%-35.71%3.32%
Enterprise Value
3,8944,3007,5967,0396,74910,111
Last Close Price
6.947.6215.9314.9715.8224.60
PE Ratio
---558.9774.81138.22
PS Ratio
3.913.384.513.384.237.37
PB Ratio
6.466.668.575.706.3110.72
P/TBV Ratio
14.3113.8212.597.117.0312.25
P/FCF Ratio
11.3257.33----
P/OCF Ratio
9.3422.28-214.7026.8597.29
EV/Sales Ratio
5.484.775.373.924.457.47
EV/EBITDA Ratio
---94.9846.9486.08
EV/EBIT Ratio
---323.7369.20139.08
EV/FCF Ratio
15.8880.86----
Debt / Equity Ratio
2.672.561.881.210.670.54
Debt / EBITDA Ratio
---15.904.604.13
Debt / FCF Ratio
4.6822.05----
Net Debt / Equity Ratio
2.502.391.540.710.200.01
Net Debt / EBITDA Ratio
-9.70-17.52-5.5810.241.420.10
Net Debt / FCF Ratio
4.3720.58-3.75-1.65-1.33-0.33
Asset Turnover
0.260.320.480.680.740.83
Inventory Turnover
1.581.822.053.613.022.74
Quick Ratio
0.390.360.470.950.891.07
Current Ratio
0.630.610.851.271.181.37
Return on Equity (ROE)
-56.33%-47.34%-29.83%1.63%8.71%7.53%
Return on Assets (ROA)
-4.80%-3.59%-5.89%0.52%2.99%2.77%
Return on Invested Capital (ROIC)
-14.00%-9.29%-15.00%0.90%7.87%6.90%
Return on Capital Employed (ROCE)
-17.90%-13.80%-18.20%1.20%7.80%7.50%
Earnings Yield
-12.27%-9.43%-4.31%0.18%1.34%0.72%
FCF Yield
8.83%1.74%-4.79%-7.60%-2.40%-0.35%
Dividend Yield
---0.83%--
Payout Ratio
---290.87%16.75%102.23%
Buyback Yield / Dilution
0.04%-0.34%-9.97%11.35%-1.81%-5.55%
Total Shareholder Return
0.04%-0.34%-9.97%12.18%-1.81%-5.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.